Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal Study

Background It is well known that high serum ferritin, a marker of iron storage, predicts incident type 2 diabetes. Limited information is available on the association between transferrin, another marker of iron metabolism, and type 2 diabetes. Thus, we investigated the association between transferri...

Full description

Bibliographic Details
Main Authors: Jong Dai Kim, Dong-Mee Lim, Keun-Young Park, Se Eun Park, Eun Jung Rhee, Cheol-Young Park, Won-Young Lee, Ki Won Oh
Format: Article
Language:English
Published: Academya Publishing Co. 2020-09-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://www.e-enm.org/upload/pdf/enm-2020-721.pdf
id doaj-2ac4d046bcab48438870454993f50896
record_format Article
spelling doaj-2ac4d046bcab48438870454993f508962020-11-25T03:54:38ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782020-09-0135361061710.3803/EnM.2020.7212079Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal StudyJong Dai Kim0Dong-Mee Lim1Keun-Young Park2Se Eun Park3Eun Jung Rhee4Cheol-Young Park5Won-Young Lee6Ki Won Oh7 Division of Endocrinology, Department of Internal Medicine, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea Division of Endocrinology, Department of Internal Medicine, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea Division of Endocrinology, Department of Internal Medicine, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, KoreaBackground It is well known that high serum ferritin, a marker of iron storage, predicts incident type 2 diabetes. Limited information is available on the association between transferrin, another marker of iron metabolism, and type 2 diabetes. Thus, we investigated the association between transferrin and incident type 2 diabetes. Methods Total 31,717 participants (mean age, 40.4±7.2 years) in a health screening program in 2005 were assessed via cross-sectional analysis. We included 30,699 subjects who underwent medical check-up in 2005 and 2009 and did not have type 2 diabetes at baseline in this retrospective longitudinal analysis. Results The serum transferrin level was higher in the type 2 diabetes group than in the non-type 2 diabetes group (58.32±7.74 μmol/L vs. 56.17±7.96 μmol/L, P<0.001). Transferrin correlated with fasting serum glucose and glycosylated hemoglobin in the correlational analysis (r=0.062, P<0.001 and r=0.077, P<0.001, respectively) after full adjustment for covariates. Transferrin was more closely related to homeostasis model assessment of insulin resistance than to homeostasis model assessment of β cell function (r=0.042, P<0.001 and r=−0.019, P=0.004, respectively) after full adjustment. Transferrin predicted incident type 2 diabetes in non-type 2 diabetic subjects in a multivariate linear regression analysis; the odds ratio (95% confidence interval [CI]) of the 3rd tertile compared to that in the 1st tertile of transferrin for incident diabetes was 1.319 (95% CI, 1.082 to 1.607) after full adjustment (P=0.006). Conclusion Transferrin is positively associated with incident type 2 diabetes in Koreans.http://www.e-enm.org/upload/pdf/enm-2020-721.pdftransferrindiabetes mellitus, type 2insulin resistance
collection DOAJ
language English
format Article
sources DOAJ
author Jong Dai Kim
Dong-Mee Lim
Keun-Young Park
Se Eun Park
Eun Jung Rhee
Cheol-Young Park
Won-Young Lee
Ki Won Oh
spellingShingle Jong Dai Kim
Dong-Mee Lim
Keun-Young Park
Se Eun Park
Eun Jung Rhee
Cheol-Young Park
Won-Young Lee
Ki Won Oh
Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal Study
Endocrinology and Metabolism
transferrin
diabetes mellitus, type 2
insulin resistance
author_facet Jong Dai Kim
Dong-Mee Lim
Keun-Young Park
Se Eun Park
Eun Jung Rhee
Cheol-Young Park
Won-Young Lee
Ki Won Oh
author_sort Jong Dai Kim
title Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal Study
title_short Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal Study
title_full Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal Study
title_fullStr Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal Study
title_full_unstemmed Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal Study
title_sort serum transferrin predicts new-onset type 2 diabetes in koreans: a 4-year retrospective longitudinal study
publisher Academya Publishing Co.
series Endocrinology and Metabolism
issn 2093-596X
2093-5978
publishDate 2020-09-01
description Background It is well known that high serum ferritin, a marker of iron storage, predicts incident type 2 diabetes. Limited information is available on the association between transferrin, another marker of iron metabolism, and type 2 diabetes. Thus, we investigated the association between transferrin and incident type 2 diabetes. Methods Total 31,717 participants (mean age, 40.4±7.2 years) in a health screening program in 2005 were assessed via cross-sectional analysis. We included 30,699 subjects who underwent medical check-up in 2005 and 2009 and did not have type 2 diabetes at baseline in this retrospective longitudinal analysis. Results The serum transferrin level was higher in the type 2 diabetes group than in the non-type 2 diabetes group (58.32±7.74 μmol/L vs. 56.17±7.96 μmol/L, P<0.001). Transferrin correlated with fasting serum glucose and glycosylated hemoglobin in the correlational analysis (r=0.062, P<0.001 and r=0.077, P<0.001, respectively) after full adjustment for covariates. Transferrin was more closely related to homeostasis model assessment of insulin resistance than to homeostasis model assessment of β cell function (r=0.042, P<0.001 and r=−0.019, P=0.004, respectively) after full adjustment. Transferrin predicted incident type 2 diabetes in non-type 2 diabetic subjects in a multivariate linear regression analysis; the odds ratio (95% confidence interval [CI]) of the 3rd tertile compared to that in the 1st tertile of transferrin for incident diabetes was 1.319 (95% CI, 1.082 to 1.607) after full adjustment (P=0.006). Conclusion Transferrin is positively associated with incident type 2 diabetes in Koreans.
topic transferrin
diabetes mellitus, type 2
insulin resistance
url http://www.e-enm.org/upload/pdf/enm-2020-721.pdf
work_keys_str_mv AT jongdaikim serumtransferrinpredictsnewonsettype2diabetesinkoreansa4yearretrospectivelongitudinalstudy
AT dongmeelim serumtransferrinpredictsnewonsettype2diabetesinkoreansa4yearretrospectivelongitudinalstudy
AT keunyoungpark serumtransferrinpredictsnewonsettype2diabetesinkoreansa4yearretrospectivelongitudinalstudy
AT seeunpark serumtransferrinpredictsnewonsettype2diabetesinkoreansa4yearretrospectivelongitudinalstudy
AT eunjungrhee serumtransferrinpredictsnewonsettype2diabetesinkoreansa4yearretrospectivelongitudinalstudy
AT cheolyoungpark serumtransferrinpredictsnewonsettype2diabetesinkoreansa4yearretrospectivelongitudinalstudy
AT wonyounglee serumtransferrinpredictsnewonsettype2diabetesinkoreansa4yearretrospectivelongitudinalstudy
AT kiwonoh serumtransferrinpredictsnewonsettype2diabetesinkoreansa4yearretrospectivelongitudinalstudy
_version_ 1724472564435124224